Mark Clemens: Our findings stress the need for enhanced screening protocols, patient education, and surgical guidelines
Mark Clemens, Associate Vice President of Perioperative Services at the University of Texas MD Anderson Cancer Center, recently posted on LinkedIn:
“New Harvard University & MD Anderson Cancer Center study examines whether any role for bacteria in biaALCL Development —
Excited to share an important systematic review, highest impact study to date exploring this controversial topic “Incidental Bystander or Essential Culprit: A Systematic Review of Bacterial Significance in the Pathogenesis of BIA-ALCL” reveals 1. An absence of compelling evidence linking bacterial biofilms to the pathogenesis of BIA-ALCL. 2. Bacteria in both control samples and BIA-ALCL cases, offering no definitive link with bacterial contamination during breast implantation. 3. International clusters of cases have meticulous implant practices, rigorous follow-up protocols, and proactive approach to CD30 screening and patient surveillance rather than any breakdown in technique. Our findings stress the need for enhanced screening protocols, patient education, and surgical guidelines. Congratulations Samuel Lin Jose Foppiani.”
For full article click here.
Source: Mark Clemens/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023